Exclusive access to monthly insights from the world’s most innovative cannabis
processor. Join over 7000+ subscribers world-wide.
Executive Officer Update
Nextleaf is pleased to announce the addition of Sam Kassem, CFA, BBA to its executive team as Interim Chief Financial Officer.
As the incoming Chief Financial Officer (“CFO”), Kassem is skilled at streamlining financial processes, implementing effective cash flow management strategies, and improving operational efficiencies that translate into revenue and operational enhancements. Kassem has been involved in the cannabis industry for 10 years. He has worked with cultivators, processors and has helped build a leading technology provider in the space.
Kevin Keagan will transition out of his role as CFO as of Sept 27th, 2023. Nextleaf would like to acknowledge Mr. Keagan’s service and involvement with the company since April 2022. Mr. Keagan remains a member of the Board of Directors.
Board of Directors Update:
Nextleaf is also pleased to announce that it has added Emma Andrews, Interim CEO, to its Board of Directors effective Sept 27th, 2023.
“Our recent appointments represent our commitment to the trajectory ahead in consumer-packaged goods and cannabis processing” says Emma Andrews. “After a deep history with the company including our go-public strategy and initial entry into branded products, I’m confident we are assembling the team and capabilities needed to support our sustained, ongoing growth” says Andrews.
About Nextleaf Solutions Ltd.
Nextleaf® is a federally regulated manufacturer and distributor of cannabis vapes and oils under its award-winning prohibition-era brand, Glacial Gold™. The Company sells its branded products through authorized distributors and retailers in 4 provinces in Canada. Nextleaf is a low-cost producer of cannabis oils, and supplier of THC and CBD ingredients to qualified wholesale partners across Canada. The Company’s multi-patented ingredient processing technology transforms cannabis and hemp biomass into high-purity distillate at an industrial scale. The Company has been issued 19 U.S. patents, and 100 patents globally, on cannabinoid processing including extraction, distillation, and acetylation. Nextleaf develops cannabinoid-based formulations and delivery technology through its Health Canada Research Licence with sensory evaluation of cannabis via human testing. Visit www.nextleafsolutions.com and www.Glacial.Gold
On behalf of the Board of Directors of the Company,
Emma Andrews, CEO
Certain statements contained in this press release constitute “forward-looking statements” within the meaning of applicable securities laws. All statements other than statements of historical fact contained in this press release, including, without limitation, statements regarding the Company’s anticipated delivery of its products to provincial markets across Canada and those regarding the Company’s strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company’s MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The Canadian Securities Exchange has not reviewed or approved the contents of this press release.
Exclusive access to monthly insights from Canada’s most innovative cannabis processor. Join over 7000+ subscribers world-wide!
By selecting yes, I certify that I am of legal age in my jurisdiction to consume cannabis.
INVEST IN THE FUTURE OF CANNABIS